Krypton laser for proliferative diabetic retinopathy: the Krypton Argon Regression of Neovascularization Study

L J Singerman; F L Ferris 3rd; R P Mowery; A J Brucker; R P Murphy; B C Lerner; G J Mincey

doi:10.1016/s0891-6632(88)80007-2

Krypton laser for proliferative diabetic retinopathy: the Krypton Argon Regression of Neovascularization Study

J Diabet Complications. 1988 Oct-Dec;2(4):189-96. doi: 10.1016/s0891-6632(88)80007-2.

Authors

L J Singerman¹, F L Ferris 3rd, R P Mowery, A J Brucker, R P Murphy, B C Lerner, G J Mincey

Affiliation

¹ Retina Associates of Cleveland, Retinal Laboratory, Ohio 44122.

PMID: 2466855
DOI: 10.1016/s0891-6632(88)80007-2

Abstract

The Krypton Argon Regression of Neovascularization Study (KARNS) is a multicenter, randomized, controlled clinical trial designed to determine the efficacy of red krypton laser photocoagulation in the treatment of proliferative diabetic retinopathy.

Publication types

Clinical Trial
Comparative Study
Randomized Controlled Trial

MeSH terms

Clinical Trials as Topic
Diabetic Retinopathy / diagnosis
Diabetic Retinopathy / surgery*
Fluorescein Angiography
Follow-Up Studies
Humans
Lasers
Light Coagulation*
Neovascularization, Pathologic
Random Allocation
Retina / blood supply